4 hours ago
1
RxSight (NASDAQ:RXST) stock dipped after the medical device company estimated second-quarter revenue to be ~$33.6M, down 4% from the prior-year period and 11% from the first quarter.
The second-quarter consensus revenue estimate stands at $39.78M (+14.02%Y/Y).
Shares were -23.85% post
English (US) ·